InVivo Therapeutics Holdings - 14 Year Stock Price History | NVIVQ
- The all-time high InVivo Therapeutics Holdings stock closing price was 425249.98 on July 22, 2013.
- The InVivo Therapeutics Holdings 52-week high stock price is 1.05, which is 228.1% above the current share price.
- The InVivo Therapeutics Holdings 52-week low stock price is 0.22, which is 31.3% below the current share price.
- The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 0.66.
InVivo Therapeutics Holdings Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 0.6440 | 0.7896 | 0.7900 | 0.2220 | 0.3207 | -56.07% |
2023 | 1.3134 | 2.2900 | 2.6300 | 0.6016 | 0.7300 | -68.94% |
2022 | 5.6725 | 13.2000 | 13.4725 | 1.7550 | 2.3500 | -79.39% |
2021 | 19.8499 | 20.3750 | 44.5000 | 11.4025 | 11.4025 | -43.69% |
2020 | 58.6882 | 157.5750 | 251.2500 | 13.1775 | 20.2500 | -87.99% |
2019 | 682.7608 | 1222.4999 | 1282.4999 | 99.2250 | 168.6750 | -85.11% |
2018 | 4855.6345 | 17062.4991 | 17062.4991 | 1049.9999 | 1132.4999 | -92.16% |
2017 | 47179.5021 | 77812.4961 | 92812.4954 | 14249.9993 | 14437.4993 | -81.67% |
2016 | 109862.3457 | 136312.4932 | 184687.4908 | 68624.9966 | 78749.9961 | -41.67% |
2015 | 202994.0375 | 97499.9951 | 333374.9833 | 97499.9951 | 134999.9933 | 36.36% |
2014 | 100752.9712 | 167999.9916 | 194999.9903 | 37499.9981 | 98999.9951 | -42.61% |
2013 | 197354.1568 | 131249.9934 | 425249.9787 | 82499.9959 | 172499.9914 | 32.18% |
2012 | 159725.9920 | 209249.9895 | 212999.9894 | 95999.9952 | 130499.9935 | -36.73% |
2011 | 90693.4479 | 146999.9927 | 232499.9884 | 44999.9978 | 206249.9897 | 22.22% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.001B | $0.000B |
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
Stryker (SYK) | United States | $136.147B | 30.68 |
Boston Scientific (BSX) | United States | $130.670B | 37.57 |
EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
Medtronic (MDT) | Ireland | $102.570B | 15.24 |
Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
ResMed (RMD) | United States | $33.995B | 27.93 |
Terumo (TRUMY) | Japan | $28.800B | 40.67 |
Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
Insulet (PODD) | United States | $17.996B | 71.67 |
Baxter (BAX) | United States | $14.756B | 9.60 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
Demant (WILYY) | Denmark | $7.926B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
Haemonetics (HAE) | United States | $3.862B | 18.85 |
ICU Medical (ICUI) | United States | $3.751B | 35.71 |
Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
Envista Holdings (NVST) | United States | $3.103B | 23.11 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
Neogen (NEOG) | United States | $2.605B | 30.05 |
LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
AtriCure (ATRC) | United States | $1.465B | 0.00 |
InMode (INMD) | Israel | $1.444B | 8.68 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
Owens & Minor (OMI) | United States | $0.973B | 7.60 |
CeriBell (CBLL) | United States | $0.958B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
Evolus (EOLS) | United States | $0.688B | 0.00 |
Omeros (OMER) | United States | $0.593B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
Surmodics (SRDX) | United States | $0.572B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
Quanterix (QTRX) | United States | $0.383B | 0.00 |
ZimVie (ZIMV) | United States | $0.373B | 31.44 |
Valneva SE (VALN) | France | $0.353B | 0.00 |
Biote (BTMD) | United States | $0.313B | 6.86 |
Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
Cerus (CERS) | United States | $0.293B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
Zynex (ZYXI) | United States | $0.268B | 56.00 |
High Tide (HITI) | Canada | $0.237B | 98.00 |
Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
Brainsway (BWAY) | Israel | $0.169B | 89.60 |
FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
Jin Medical (ZJYL) | China | $0.132B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.096B | 10.79 |
Veru (VERU) | United States | $0.092B | 0.00 |
Exagen (XGN) | United States | $0.083B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
InterCure (INCR) | Israel | $0.061B | 0.00 |
Apyx Medical (APYX) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Modular Medical (MODD) | United States | $0.050B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Safety Shot (SHOT) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 12.82 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |